Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 10—October 2013

Plasmodium vivax Malaria during Pregnancy, Bolivia

Laurent Brutus, José Santalla, Dominique Schneider, Juan Carlos Avila, and Philippe Deloron
Author affiliations: Institut de Recherche pour le Développement, Paris, France (L. Brutus, D. Schneider, P. Deloron); Université Paris Descartes, Paris (L. Brutus, D. Schneider, P. Deloron); Ministerio de Salud y Deportes, La Paz, Bolivia (J. Santalla); Vector-borne Diseases Program, Guayaramerín, Beni, Bolivia (J.C. Avila)

Main Article

Table 4

Factors associated with mean hemoglobin level and risk for moderate-to-severe anemia, excluding Plasmodium falciparum infections, during hospital-based survey, Guayaramerín and Bermejo, Bolivia, 2002–2004*

Characteristic Multiple linear regression, n = 1,439 Logistic regression, n = 1,439
Adjusted difference in mean hemoglobin level, g/dL (95% CI)† p value Adjusted OR for moderate-to-severe anemia (95% CI) p value
Primiparous mother 0 NS NS 0.23
Multiparous mother –0.28 (−0.51 to −0.06) 0.012 NS NS
Bermejo 0 NS NS 0.42
Guayaramerín –0.38 (−0.59 to −0.16) 0.001 NS NS
Noninfected placenta 0 NS 1 NS
P. vivax– infected placenta –0.70 (−1.32 to −0.09) 0.026 2.5 (1.04–6.2) 0.04

*OR, odds ratio; NS, not significant. Significant values (<0.05) are indicated in boldface. Multivariate models adjusting for number of previous pregnancies, antenatal visits, houses with indoor insecticide spraying, site of study, and delivery during transmission season. Only significant variables (p<0.10) from the linear regression model are shown. The same variables were used for the logistic regression model.
†Baseline mean hemoglobin level was 11.7 g/dL.

Main Article

Page created: August 14, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.